Malignant Skin NeoplasmNCT02373722
Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery
A study testing Mohs Surgery, Internet-Based Intervention and Telephone-Based Intervention in people with Malignant Skin Neoplasm, run by Wake Forest University Health Sciences at 1 site in United States.
Trial summary
This randomized clinical trial studies how well website application (web app) based education and text messaging works in improving skin wound care in patients undergoing Mohs surgery (a surgical procedure used to treat skin cancer). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Malignant Skin Neoplasm
- What is being tested?
- Mohs Surgery, Internet-Based Intervention and Telephone-Based Intervention
- Type of treatment
- Surgery or procedure, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2015to Mar 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient is undergoing Mohs surgery
- Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed
- The subject is able to complete the study and comply with study instructions, including attending all study visits
- The patient has a cell phone capable of receiving text messages
Who cannot join
- The patient is not indicated for Mohs surgery
- Inability to complete all study-related visits
- Non-English speaking patients
- The patient cannot receive text messages
Trial locations and contacts
1 site in 1 country.
United States1 site
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, 27157
About this study
Official title: Web App Based Patient Education in Mohs Surgery
This randomized clinical trial studies how well website application (web app) based education and text messaging works in improving skin wound care in patients undergoing Mohs surgery (a surgical procedure used to treat skin cancer). Website application and text messaging based education may help patients stick to wound care instructions before and after surgery, lower anxiety level, and may help monitor their activity.
Read the detailed description
PRIMARY OBJECTIVES:
- To create a web application which will educate dermatologic surgery patients prior to their operations with educational videos.
SECONDARY OBJECTIVES:
- To create and evaluate a web based system to send wound care instructions to patients by text message after their operation.
II. Qualitative comments from participants and research staff concerning the feasibility of this approach and the use of Fitbit activity trackers as a means to monitor movement restriction.
III. The rate of adverse events.
OUTLINE: Patients are randomized to 1 of 4 groups.
GROUP I: Patients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly twice daily (BID) to the wound area.
GROUP II: Patients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area.
GROUP III: Patients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are.
GROUP IV: Patients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area.
After completion of study, patients are followed up at 1 week.
- Conditions
- Malignant Skin Neoplasm
- Being tested
- Mohs Surgery, Internet-Based Intervention, Telephone-Based Intervention, Educational Intervention, Exercise Intervention
- Medical subject headings
- Skin Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mohs SurgeryProcedure or surgery
Undergo Mohs surgery
Internet-Based InterventionOther
Watch website application based educational video
Telephone-Based InterventionBehavioural
Receive text messages
Educational InterventionOther
Also called Education for Intervention, Intervention, Educational
Watch website application based educational video
Exercise InterventionBehavioural
Use Fitbit
Petrolatum-Mineral Oil-Lanolin-Ceresin OintmentOther
Also called Aquaphor
Applied to the wound area
Questionnaire AdministrationOther
Ancillary studies
Survey AdministrationOther
Ancillary studies
| Study group | Role | What they receive |
|---|---|---|
| Group I (video, text message) | Experimental | Patients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly BID to the wound area. Receives: Procedure: Mohs Surgery; Other: Internet-Based Intervention; Behavioral: Telephone-Based Intervention; Other: Educational Intervention; Behavioral: Exercise Intervention; Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment; Other: Questionnaire Administration; Other: Survey Administration |
| Group II (educational video) | Experimental | Patients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area Receives: Procedure: Mohs Surgery; Other: Internet-Based Intervention; Other: Educational Intervention; Behavioral: Exercise Intervention; Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment; Other: Questionnaire Administration; Other: Survey Administration |
| Group III (text message) | Experimental | Patients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are. Receives: Procedure: Mohs Surgery; Behavioral: Telephone-Based Intervention; Behavioral: Exercise Intervention; Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment; Other: Questionnaire Administration; Other: Survey Administration |
| Group IV (control) | Experimental | Patients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area. Receives: Procedure: Mohs Surgery; Behavioral: Exercise Intervention; Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment; Other: Questionnaire Administration; Other: Survey Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Preoperative anxiety score
The preoperative anxiety scores of patients randomized to receive or not receive the educational video will be compared using a t-test or appropriate non-parametric test (Wilcoxon Rank Sum or Sign test) based on the distribution of the scores.
Measured: Before surgery
Patient knowledge score
Patient knowledge scores of patients randomized to receive or not receive the educational video will be compared using a t-test or appropriate non-parametric test (Wilcoxon Rank Sum or Sign test) based on the distribution of the scores.
Measured: Up to 1 week after completion of study
Medication adherence
The mean number of times the medication was applied will be compared for the three intervention groups versus the control group.
Measured: Up to 1 week after completion of study
Secondary outcomes (3)
Patient satisfaction score
Patient satisfaction scores across the four randomization groups will be compared using analysis of variance (ANOVA) methods.
Measured: Up to 1 week after completion of study
Mobility adherence as measured by Fitbit monitor
Compare the average number of steps taken each day between groups and the cumulative number of steps taken over the whole week using ANOVA methods. Percentage of patients with average daily activity below 2500 steps will be compared using the Chi-Squared or Fisher's Exact test. All three intervention groups will be compared to the control group.
Measured: Up to 1 week after completion of study
Incidence of adverse events
The proportion of patients reporting adverse events will be compared using chi-squared tests or Fisher's exact tests, depending on the expected frequency of events. Comparisons will be made for those given versus not given the surgery education mobile app and then for those given versus not given text messages. To look at all four groups independently, a global statistic will be initially calculated. If significant, comparisons between the four groups will be made.
Measured: Up to 1 week after completion of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2015 (estimated)
- Study startMar 2015
- Primary completionMar 2016
- Study completionMar 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Malignant Skin NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Daniel Pearce, Principal investigator, Wake Forest University Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02373722
- Sponsor's protocol ID
- IRB00028840
- Other IDs
- NCI-2015-00217, CCCWFU 01714, P30CA012197
- Status last verified
- Jun 2018
- First submitted
- 23 Feb 2015
- Last updated
- 3 Jul 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Web App Based Patient Education in Mohs Surgery
- ClinicalTrials.gov ID
- NCT02373722
- Acronym / sponsor ID
- IRB00028840
- Conditions
- Malignant Skin Neoplasm
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Wake Forest University Health SciencesUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- Mar 2015 (actual)
- Primary completion
- Mar 2016 (actual)
- Study completion
- Mar 2016 (actual)
- First posted
- 27 Feb 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical trial studies how well website application (web app) based education and text messaging works in improving skin wound care in patients undergoing Mohs surgery (a surgical procedure used to treat skin cancer). Website application and text messaging based education may help patients stick to wound care instructions before and after surgery, lower anxiety level, and may help monitor their activity.
Detailed description
PRIMARY OBJECTIVES:
- To create a web application which will educate dermatologic surgery patients prior to their operations with educational videos.
SECONDARY OBJECTIVES:
- To create and evaluate a web based system to send wound care instructions to patients by text message after their operation.
II. Qualitative comments from participants and research staff concerning the feasibility of this approach and the use of Fitbit activity trackers as a means to monitor movement restriction.
III. The rate of adverse events.
OUTLINE: Patients are randomized to 1 of 4 groups.
GROUP I: Patients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly twice daily (BID) to the wound area.
GROUP II: Patients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area.
GROUP III: Patients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are.
GROUP IV: Patients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area.
After completion of study, patients are followed up at 1 week.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Group I (video, text message) | Experimental | Procedure: Mohs Surgery, Other: Internet-Based Intervention, Behavioral: Telephone-Based Intervention, Other: Educational Intervention, Behavioral: Exercise Intervention, Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Other: Questionnaire Administration, Other: Survey AdministrationPatients watch an educational video about Mohs surgery before their surgery, a video about wound care after the surgery and receive text messages about wound care on days 1-5 after the surgery. Patients also receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are instructed to apply petroleum jelly BID to the wound area. |
| Group II (educational video) | Experimental | Procedure: Mohs Surgery, Other: Internet-Based Intervention, Other: Educational Intervention, Behavioral: Exercise Intervention, Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Other: Questionnaire Administration, Other: Survey AdministrationPatients watch an educational video about Mohs surgery before their surgery, an educational video about wound care after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients apply petroleum jelly BID to the wound area |
| Group III (text message) | Experimental | Procedure: Mohs Surgery, Behavioral: Telephone-Based Intervention, Behavioral: Exercise Intervention, Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Other: Questionnaire Administration, Other: Survey AdministrationPatients receive text messages about wound care on days 1-5 after the surgery and receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound are. |
| Group IV (control) | Experimental | Procedure: Mohs Surgery, Behavioral: Exercise Intervention, Other: Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Other: Questionnaire Administration, Other: Survey AdministrationPatients receive no video or text messages. Patients receive instructions to reduce movement and use a Fitbit activity tracker. Beginning 48 hours after surgery, patients are also instructed to apply petroleum jelly BID to the wound area. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- The patient is undergoing Mohs surgery
- Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed
- The subject is able to complete the study and comply with study instructions, including attending all study visits
- The patient has a cell phone capable of receiving text messages
Key exclusion criteria (4 listed)
- The patient is not indicated for Mohs surgery
- Inability to complete all study-related visits
- Non-English speaking patients
- The patient cannot receive text messages
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mohs SurgeryUndergo Mohs surgery | Procedure or surgery | Group I (video, text message), Group II (educational video), Group III (text message), Group IV (control) |
| Internet-Based InterventionWatch website application based educational video | Other | Group I (video, text message), Group II (educational video) |
| Telephone-Based InterventionReceive text messages | Behavioural | Group I (video, text message), Group III (text message) |
| Educational InterventionAlso: Education for Intervention, Intervention, EducationalWatch website application based educational video | Other | Group I (video, text message), Group II (educational video) |
| Exercise InterventionUse Fitbit | Behavioural | Group I (video, text message), Group II (educational video), Group III (text message), Group IV (control) |
| Petrolatum-Mineral Oil-Lanolin-Ceresin OintmentAlso: AquaphorApplied to the wound area | Other | Group I (video, text message), Group II (educational video), Group III (text message), Group IV (control) |
| Questionnaire AdministrationAncillary studies | Other | Group I (video, text message), Group II (educational video), Group III (text message), Group IV (control) |
| Survey AdministrationAncillary studies | Other | Group I (video, text message), Group II (educational video), Group III (text message), Group IV (control) |
Primary outcome
Preoperative anxiety score
Time frame: Before surgery
The preoperative anxiety scores of patients randomized to receive or not receive the educational video will be compared using a t-test or appropriate non-parametric test (Wilcoxon Rank Sum or Sign test) based on the distribution of the scores.
Patient knowledge score
Time frame: Up to 1 week after completion of study
Patient knowledge scores of patients randomized to receive or not receive the educational video will be compared using a t-test or appropriate non-parametric test (Wilcoxon Rank Sum or Sign test) based on the distribution of the scores.
Medication adherence
Time frame: Up to 1 week after completion of study
The mean number of times the medication was applied will be compared for the three intervention groups versus the control group.
3 secondary outcomes
Patient satisfaction score
Time frame: Up to 1 week after completion of study
Mobility adherence as measured by Fitbit monitor
Time frame: Up to 1 week after completion of study
Incidence of adverse events
Time frame: Up to 1 week after completion of study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2018.
Related trials for Malignant Skin Neoplasm
RecruitingPhase 2
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia
RecruitingPhase 2
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
RecruitingObservational study
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Solid Tumor, Adult, Colorectal Cancer
RecruitingObservational study
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Breast Cancer, Breast Carcinoma
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daniel Pearce principal investigator
Wake Forest University Health Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mohs Surgery, Internet-Based Intervention and Telephone-Based Intervention in people with Malignant Skin Neoplasm, run by Wake Forest University Health Sciences at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Preoperative anxiety score (time frame: Before surgery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2018.